Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Lack of benefit of temozolomide for MGMT methylated patients with high vascular glioblastoma: a confirmatory study

María del Mar Álvarez-Torres, Elies Fuster-García, Carmen Balaña, Josep Puig, Juan Miguel García-Gómez
doi: https://doi.org/10.1101/2021.09.01.21262673
María del Mar Álvarez-Torres
1Universitat Politècnica de València, ITACA, Biomedical Data Science Laboratory. Valencia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: maaltor4{at}upv.es
Elies Fuster-García
2Oslo University Hospital, Department of Diagnostic Physics. Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carmen Balaña
3Institut Catala Oncologia Badalona. Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josep Puig
4Institut de Diagnostic per la Image (IDI), Hospital Dr Josep Trueta. Girona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan Miguel García-Gómez
1Universitat Politècnica de València, ITACA, Biomedical Data Science Laboratory. Valencia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Article usage

Article usage: September 2021 to June 2025

AbstractFullPdf
Sep 202111875372
Oct 202171139
Nov 202171513
Dec 202142311
Jan 20221662
Feb 20222049
Mar 20223222
Apr 20223245
May 20222008
Jun 20222414
Jul 20221702
Aug 20221822
Sep 20222819
Oct 20223028
Nov 20221713
Dec 20222105
Jan 20232069
Feb 20231635
Mar 20231220
Apr 20231621
May 2023912
Jun 2023852
Jul 2023410
Aug 202315126
Sep 20231152
Oct 2023711
Nov 202321240
Dec 2023813
Jan 20241035
Feb 20241023
Mar 2024304
Apr 2024625
May 2024733
Jun 202413107
Jul 202410213
Aug 2024856
Sep 20241623
Oct 2024612
Nov 2024915
Dec 2024725
Jan 2025927
Feb 20254233
Mar 202520328
Apr 20251616
May 202511911
Jun 2025723
Back to top
PreviousNext
Posted September 03, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Lack of benefit of temozolomide for MGMT methylated patients with high vascular glioblastoma: a confirmatory study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Lack of benefit of temozolomide for MGMT methylated patients with high vascular glioblastoma: a confirmatory study
María del Mar Álvarez-Torres, Elies Fuster-García, Carmen Balaña, Josep Puig, Juan Miguel García-Gómez
medRxiv 2021.09.01.21262673; doi: https://doi.org/10.1101/2021.09.01.21262673
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Lack of benefit of temozolomide for MGMT methylated patients with high vascular glioblastoma: a confirmatory study
María del Mar Álvarez-Torres, Elies Fuster-García, Carmen Balaña, Josep Puig, Juan Miguel García-Gómez
medRxiv 2021.09.01.21262673; doi: https://doi.org/10.1101/2021.09.01.21262673

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Oncology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)